Lee S - Search Results

1

The telomere maintenance mechanism spectrum and its dynamics in gliomas.

Kim S, Chowdhury T, Yu HJ, Kahng JY, Lee CE, Choi SA, Kim KM, Kang H, Lee JH, Lee ST, Won JK, Kim KH, Kim MS, Lee JY, Kim JW, Kim YH, Kim TM, Choi SH, Phi JH, Shin YK, Ku JL, Lee S, Yun H, Lee H, Kim D, Kim K, Hur JK, Park SH, Kim SK, Park CK. Kim S, et al. Among authors: lee h, lee jy, lee jh, lee st, lee s, lee ce. Genome Med. 2022 Aug 11;14(1):88. doi: 10.1186/s13073-022-01095-x. Genome Med. 2022. PMID: 35953846 Free PMC article.

2

Let-7 microRNA inhibits the proliferation of human glioblastoma cells.

Lee ST, Chu K, Oh HJ, Im WS, Lim JY, Kim SK, Park CK, Jung KH, Lee SK, Kim M, Roh JK. Lee ST, et al. J Neurooncol. 2011 Mar;102(1):19-24. doi: 10.1007/s11060-010-0286-6. Epub 2010 Jul 7. J Neurooncol. 2011. PMID: 20607356

3

Expression level of hTERT is regulated by somatic mutation and common single nucleotide polymorphism at promoter region in glioblastoma.

Park CK, Lee SH, Kim JY, Kim JE, Kim TM, Lee ST, Choi SH, Park SH, Kim IH. Park CK, et al. Oncotarget. 2014 May 30;5(10):3399-407. doi: 10.18632/oncotarget.1975. Oncotarget. 2014. PMID: 24930669 Free PMC article.

4

C-MET overexpression and amplification in gliomas.

Kwak Y, Kim SI, Park CK, Paek SH, Lee ST, Park SH. Kwak Y, et al. Int J Clin Exp Pathol. 2015 Nov 1;8(11):14932-8. eCollection 2015. Int J Clin Exp Pathol. 2015. PMID: 26823824 Free PMC article.

5

Predictors of survival for patients with cancer after cryptogenic stroke.

Shin YW, Lee ST, Jung KH, Kim DY, Park CK, Kim TM, Choi SH, Chu K, Lee SK. Shin YW, et al. J Neurooncol. 2016 Jun;128(2):277-84. doi: 10.1007/s11060-016-2106-0. Epub 2016 Mar 11. J Neurooncol. 2016. PMID: 26968716

6

Prognosis prediction of non-enhancing T2 high signal intensity lesions in glioblastoma patients after standard treatment: application of dynamic contrast-enhanced MR imaging.

Kim R, Choi SH, Yun TJ, Lee ST, Park CK, Kim TM, Kim JH, Park SW, Sohn CH, Park SH, Kim IH. Kim R, et al. Eur Radiol. 2017 Mar;27(3):1176-1185. doi: 10.1007/s00330-016-4464-6. Epub 2016 Jun 29. Eur Radiol. 2017. PMID: 27357131

7

Underexpression of HOXA11 Is Associated with Treatment Resistance and Poor Prognosis in Glioblastoma.

Se YB, Kim SH, Kim JY, Kim JE, Dho YS, Kim JW, Kim YH, Woo HG, Kim SH, Kang SH, Kim HJ, Kim TM, Lee ST, Choi SH, Park SH, Kim IH, Kim DG, Park CK. Se YB, et al. Cancer Res Treat. 2017 Apr;49(2):387-398. doi: 10.4143/crt.2016.106. Epub 2016 Jul 19. Cancer Res Treat. 2017. PMID: 27456940 Free PMC article.

8

The survival significance of a measurable enhancing lesion after completing standard treatment for newly diagnosed glioblastoma.

Kim SK, Kim TM, Lee ST, Lee SH, Heo DS, Kim IH, Kim DG, Jung HW, Choi SH, Lee SH, Park CK. Kim SK, et al. J Clin Neurosci. 2016 Dec;34:145-150. doi: 10.1016/j.jocn.2016.06.014. Epub 2016 Jul 27. J Clin Neurosci. 2016. PMID: 27475318

9

MR Imaging Analysis of Non-Measurable Enhancing Lesions Newly Appearing after Concomitant Chemoradiotherapy in Glioblastoma Patients for Prognosis Prediction.

Kim BR, Choi SH, Yun TJ, Lee ST, Park CK, Kim TM, Kim JH, Park SW, Sohn CH, Park SH, Kim IH. Kim BR, et al. PLoS One. 2016 Nov 11;11(11):e0166096. doi: 10.1371/journal.pone.0166096. eCollection 2016. PLoS One. 2016. PMID: 27835666 Free PMC article.

10

Dynamic contrast-enhanced MR imaging in predicting progression of enhancing lesions persisting after standard treatment in glioblastoma patients: a prospective study.

Yoo RE, Choi SH, Kim TM, Park CK, Park SH, Won JK, Kim IH, Lee ST, Choi HJ, You SH, Kang KM, Yun TJ, Kim JH, Sohn CH. Yoo RE, et al. Eur Radiol. 2017 Aug;27(8):3156-3166. doi: 10.1007/s00330-016-4692-9. Epub 2016 Dec 14. Eur Radiol. 2017. PMID: 27975145

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

127,600 results

Search Page